An increasing demand for minimally invasive surgeries amongst the rapidly
aging population is expected to spark further growth in the cardiovascular
devices market. Moreover, the cost efficiencies offered by lesser invasive
methods expect to garner much favor amongst the healthcare payers as well.
Frost & Sullivan finds that North American Cardiovascular Devices Market
earned revenues of $17.88 billion in 2005 and estimates this to reach $40.46
billion in 2011.
If you are interested in a virtual brochure, which provides manufacturers,
end users, and other industry participants an overview of the latest analysis of
the North American Cardiovascular Devices Market: Investment Analysis and Growth
Opportunities, then send an e-mail to Melina Trevino – Corporate Communications
at melina.trevino@frost.com with the following information: your full name,
company name, title, telephone number, e-mail address, city, state, and country.
We will send you the information via email upon receipt of the above
information.
By 2030, estimates of people aged 65 years and above will constitute 20
percent of the U.S. population, up 12.5 percent from 2005. This sector poses a
significant opportunity for the cardiovascular devices industry, as the
occurrence of heart related diseases is the highest in this age group.
“Demographics, historically has and will continue to be one of the major
factors that drive growth in the cardiovascular devices market,” notes Frost &
Sullivan Financial Analyst Sheetal Rajani.
Minimally invasive surgeries are gaining ground with both the patient
population as well as cardiologists. These surgeries are associated with lesser
trauma, shorter recovery time and lesser postoperative pain for the patient.
Cardiologists stand to gain from the same too as the number of surgeries
performed at a given time can increase.
“Companies need to continually invest in research and development in order to
develop devices that could convert a surgery from an in-patient to an outpatient
setting,” explains Rajani. “This will guarantee strong revenue growth and
provide enhanced value to the patients as well as cardiologists.”
North American Cardiovascular Devices Market:
Investment Analysis and Growth Opportunities is part of the Financial
Benchmarking and Analysis in the Medical Devices Industry Subscription, which
also includes research in the following: World Medical Devices Industry:
Investment Analysis and Growth Opportunities. All research included in
subscriptions provide detailed market opportunities and industry trends that
have been evaluated following extensive interviews with market participants.
Interviews are available to the press.
Frost & Sullivan, a global growth consulting company, has been partnering
with clients to support the development of innovative strategies for more than
40 years. The company’s industry expertise integrates growth consulting, growth
partnership services, and corporate management training to identify and develop
opportunities. Frost & Sullivan serves an extensive clientele that includes
Global 1000 companies, emerging companies, and the investment community by
providing comprehensive industry coverage that reflects a unique global
perspective and combines ongoing analysis of markets, technologies, econometrics,
and demographics. For more information, visit http://www.frost.com.
;
Contacts:
Melina Trevino
Corporate Communications – North America
P: 210.247.2440
F: 210.348.1003
E: melina.trevino@frost.com
;
Radhika Menon Theodore
Corporate Communications
P: +91 (044) 42044541
E: rmtheodore@frost.com
;
Jasminder Kaur
Corporate Communications – Asia Pacific
P: 65.6890.0937
F: 65.6890.0988
E: jasminder.kaur@frost.com
;
Surbhi Dedhia
Corporate Communications – India
P: +91 22 2832 4705 Ext: 131
E: sdedhia@frost.com